Viyash Scientific Ltd

Viyash Scientific Limited, formerly Sequent Scientific Limited, announced that its Nomination and Remuneration Committee has approved the allotment of 1,35,880 equity shares, comprising 79,000 shares at a price of Rs 86 each under the Sequent Scientific Limited Employee Stock Option Plan 2020 and 56,880 shares at a price of Rs 101 each under the Viyash Scientific Limited Employee Stock Option Scheme 2026. The allotment increases the company’s issued and paid-up equity share capital from Rs 88,32,55,340 with 44,16,27,670 shares to Rs 88,35,27,100 with 44,17,63,550 shares.

Viyash Scientific Limited, formerly known as Sequent Scientific Limited, informed the BSE Limited and National Stock Exchange of India Limited that KFin Technologies Limited, its Registrar and Share Transfer Agent, has issued a certificate regarding the dematerialization and rematerialization of securities for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Viyash Scientific Limited, formerly Sequent Scientific Limited, announced that its step-down wholly owned subsidiary, Alivira Animal Health Limited, Ireland, has completed the acquisition of 100% of the share capital of BioForLife Italia S.r.l., Milan, Italy, on October 1, 2026, as per a Sale and Purchase Agreement dated July 21, 2026; the transaction included a base purchase consideration of EUR 15.0 million and a deferred consideration of EUR 1.976 million, payable subject to adjustments.

Viyash Scientific Limited, formerly known as Sequent Scientific Limited, will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ending September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Viyash Scientific Limited, formerly Sequent Scientific Limited, announced that its Nomination and Remuneration Committee has approved the allotment of 11,07,309 equity shares following the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 and the Viyash Scientific Limited Employee Stock Option Scheme 2026; 9,26,333 shares were allotted at a price of Rs. 86 per share and 1,80,976 shares at Rs. 101 per share.

Viyash Scientific Limited, formerly Sequent Scientific Limited, announced that its Nomination and Remuneration Committee approved the allotment of 6,12,773 equity shares, comprised of 2,30,001 shares at a price of Rs 86 per share under the Sequent Scientific Limited Employee Stock Option Plan 2020 and 3,82,772 shares at a price of Rs 101 per share under the Viyash Scientific Limited Employee Stock Option Scheme 2026. The allotment increased the company’s issued and paid-up equity share capital from Rs 87,98,15,176 consisting of 43,99,07,588 equity shares to Rs 88,10,40,722 consisting of 44,05,20,361 equity shares.

Premier Energies Ltd, Tanla Platforms Ltd, Jana Small Finance Bank Ltd and Varun Beverages Ltd are among the other losers in the BSE's 'A' group today, 26 August 2026.Viyash Scientific Ltd crashed 5.43% to Rs 263.1 at 14:48 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 103.44 lakh shares were traded on the counter so far as against the average daily volumes of 1.97 lakh shares in the past one month.Premier Energies Ltd lost 4.42% to Rs 985.55. The stock was the second biggest loser in 'A' group.On the BSE, 2.01 lakh shares were traded on the counter so far as against the average daily volumes of 55227 shares in the past one month.Tanla Platforms Ltd tumbled 3.98% to Rs 533.5. The stock was the third biggest loser in 'A' group.On the BSE, 51587 shares were traded on the counter so far as against the average daily volumes of 50078 shares in the past one month.Jana Small Finance Bank Ltd fell 3.94% to Rs 547.55. The stock was the fourth biggest loser in 'A' group.On the BSE, 82855 shares were traded on the counter so far as against the average daily volumes of 1.22 lakh shares in the past one month.Varun Beverages Ltd shed 3.68% to Rs 421.9. The stock was the fifth biggest loser in 'A' group.On the BSE, 9.44 lakh shares were traded on the counter so far as against the average daily volumes of 4.5 lakh shares in the past one month.

Viyash Scientific Ltd share price softened by 1.19% to Rs 273.8. The Company's net profit rose by 19.45% to Rs 79.29 crore, while revenue from operations slightly gained 2.87% to Rs 946.36 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.56 lakh crore, gaining 4.63%. It has improved by 0.56% over last one week and heading higher by 13.27% in last one month while the market capitalization of Viyash Scientific Ltd has inched up 2.76% and 21.93% in the same period respectively. Profit before tax (PBT) of Viyash Scientific Ltd stood at Rs 112.41 crore in Q2 FY26, expanding by 132.54% year-on-year, and dropping 10.24% quarter-on-quarter. EBITDA came in at Rs 170 crore, rallying 51.94% YoY and easing 1.03% sequentially. Total expenses posted a minor rise of 4.22% to Rs 829.75 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 402.34 crore, going up by 10.56% YoY, while employee benefits expense was at Rs 162.65 crore, rising by 8.56% YoY. For the TTM ended FY26, revenue from operations grew 13.75% to Rs 3420.31 crore, while net profit surged by 1324.54% to Rs 224.65 crore, compared to previous TTM. EBITDA jumped by 34797% to Rs 608.98 crore, and PBT jumped 2548.10% to Rs 349.02 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 322.91 crore in FY26, as against Rs 344.8 crore in FY25. Viyash Scientific Ltd soared by 54.86% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.

Viyash Scientific Limited, formerly known as Sequent Scientific Limited, will hold a board meeting on Tuesday, August 11, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing. The trading window for the company's securities remains closed from July 1, 2026, until August 13, 2026, in accordance with insider trading regulations.

Viyash Scientific Limited, formerly Sequent Scientific Limited, announced that its Nomination and Remuneration Committee approved the allotment of 20,01,336 equity shares of Rs 2 each, fully paid, to eligible optionees at an exercise price of Rs 86 per share under the SeQuent ESOP 2020, increasing the company’s issued and paid-up equity share capital from Rs 87,37,50,954 consisting of 43,68,75,477 equity shares to Rs 87,77,53,626 consisting of 43,88,76,813 equity shares.